SCHEMBL6553315

SCHEMBL6553315

CC(=O)N[C@@H]1[C@H](O[C@H]2O[C@H](CO)[C@H](OCc3ccccc3)[C@H](O)[C@H]2OCc2ccccc2)O[C@H](CO)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 4/20 0.47
▸ MAG P20916 1/20 0.46
▸ LGALS7; LGALS7B P47929 2/20 0.45
▸ LGALS1 P09382 1/20 0.45
▸ LGALS9 O00182 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ LGALS8 O00214 1/20 0.44
▸ HRAS P01112 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MDM2 Q00987 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793063 0.87 PTPN1 (0.48) LGALS3MAGLGALS7; LGALS7BLGALS1SLC6A2
SCHEMBL7774709 0.86 MAPK1 (0.50) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL25913957 0.86 TP53 (0.47) LGALS3MAGLGALS7; LGALS7BLGALS1LGALS9
SCHEMBL5841006 0.84 MAG (0.55) LGALS3MAGSLC6A2LGALS8HRAS
SCHEMBL22204678 0.84 MAG (0.55) LGALS3MAGSLC6A2LGALS8HRAS
SCHEMBL5841001 0.84 MAG (0.55) LGALS3MAGSLC6A2LGALS8HRAS
SCHEMBL5841546 0.84 MAG (0.55) LGALS3MAGSLC6A2LGALS8HRAS
SCHEMBL13491610 0.82 MAPK1 (0.48) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8
SCHEMBL7233754 0.82 L3MBTL1 (0.44) LGALS3MAGLGALS7; LGALS7BLGALS1LGALS9
SCHEMBL12128062 0.82 TACR2 (0.45) LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1018515-B1 Oligosaccharide, method for producing it and pharmaceutical composition containing it SEIKAGAKU KOGYO CO LTD (JP) 2004-02-18 — — EP disclosed
US-6562954-B1 Oligosaccharide for use as tool in human therapeutics SEIKAGAKU CORPORATION (JP) 2003-05-13 — — US disclosed
EP-1018515-A1 Oligosaccharide, method for producing it and pharmaceutical composition containing it SEIKAGAKU CORPORATION (JP) 2000-07-12 — — EP disclosed
Send feedback